Literature DB >> 12115319

Fas/Fas ligand system and apoptosis induction in testicular carcinoma.

Hans U Schmelz1, Michael Abend, Klaus Kraft, Ekkehard W Hauck, Wolfgang Weidner, Dirk Van Beuningen, Christoph Sparwasser.   

Abstract

BACKGROUND: Tumor-infiltrating, Fas ligand (FasL)-expressing lymphocytes are able to eliminate Fas-bearing tumor cells by apoptosis induction. Activated cytotoxic T-cells that express Fas may enter apoptosis in the presence of FasL tumor cells. To date, no studies of patients with testicular carcinoma have correlated the differential expression of Fas and FasL in both cell types with the corresponding apoptotic index (AI).
METHODS: Fas and FasL were investigated immunohistochemically in paraffin embedded tissue sections from 25 patients with nonseminomatous testicular tumors. The percentages of positive cells and the ratios of Fas cells to FasL cells were correlated with the AI of tumor cells and lymphocytes, respectively, using Spearman correlations.
RESULTS: No association was found between the rate of FasL positive cells and AI of the other cell type or between the rate of Fas positive cells and the AI of the same cell type. Ratios between Fas positive cells and FasL positive cells were not correlated with the AI; however, a significant positive correlation was found between the AI of tumor cells and the AI of lymphocytes.
CONCLUSIONS: It seems unlikely that the Fas/FasL system is responsible for immune escape of the tumor in testicular carcinoma. Rather, the significant positive correlation between the AIs of tumor cells and lymphocytes implicate a previously unknown mechanism of apoptosis induction in both cell types. Copyright 2002 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12115319     DOI: 10.1002/cncr.10649

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Comparative analysis of different apoptosis detection methods in human testicular cancer.

Authors:  Hans Ulrich Schmelz; Michael Abend; Matthias Port; Michael Schwerer; Ekkehard W Hauck; Wolfgang Weidner; Christoph Sparwasser
Journal:  Urol Res       Date:  2004-04-29

2.  Significance of apoptosis in metastasizing testis tumors.

Authors:  M Abend; M Port; H U Schmelz; K Kraft; C Sparwasser
Journal:  Urol Res       Date:  2003-10-25

Review 3.  Immune-Related Concepts in Biology and Treatment of Germ-Cell Tumors.

Authors:  Michal Chovanec; Ugo De Giorgi; Michal Mego
Journal:  Adv Urol       Date:  2018-03-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.